Please provide your email address to receive an email when new articles are posted on . The MPN Landmark Study included data from 813 patients with myeloproliferative neoplasms — including ...

There are promising drugs for myeloproliferative neoplasms coming down the pipeline. It is an exciting time for the treatment of myeloproliferative neoplasms (MPNs), as new treatments continue to ...

Ruben Mesa, M.D.,Rami S. Komrokji, M.D. Experts Rami Komrokji, MD, and Ruben Mesa, MD, define myeloproliferative neoplasms (MPNs) and explain differences between ...

Please provide your email address to receive an email when new articles are posted on . Ruxolitinib (Jakafi, Incyte) significantly improved some disease-related symptoms; however, rates of thrombosis, ...

The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs) RAHWAY, N.J.--(BUSINESS WIRE)-- Merck ...

A new large-scale study of patients with myeloproliferative neoplasm finds they are at twice the risk of mortality from respiratory disease. Patients with myeloproliferative neoplasm have roughly ...

Selected plenary presentation highlights positive Phase 3 SURPASS-ET clinical trial results of ropeginterferon alfa-2b-njft for the treatment of essential thrombocythemia (ET) Additional oral ...

Myeloproliferative neoplasms (MPNs) are currently diagnosed according to the World Health Organization (WHO) criteria. Molecular profiling should include the analysis of JAK2 V617F (first, exon 12 ...

—MedPage Today spoke with Jerry Spivak, MD, Director of the Johns Hopkins Center for the Chronic Myeloproliferative Disorders, about his latest review article and the difficulties inherent in the ...

Myeloproliferative neoplasms have varied progression rates, and a complex genetic landscape may contribute to heterogeneity in the outcomes of patients with these diseases. Myeloproliferative ...

CHICAGO, IL, UNITED STATES, December 14, 2022 /EINPresswire.com/ -- MPN Research Foundation (MPNRF) announces its 2022 Thrive Initiative recipients for projects that ...